-
Price Momentum
FTH is trading near the top of its 52-week range and above its 200-day simple moving average.
-
Price change
The price of FTH shares has increased $0.73 since the market last closed. This is a 2.23% rise.
-
Opened at $33.69.
The stock opened $0.72 higher than its previous close.
Key terms
About FTH
Faeth Therapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Austin, TX.
-
Market cap: $851.96M
A market capitalization between $300 million and $2 billion places FTH in the small capitalization category.
Key terms
Smart score
Latest FTH news
No recent press releases are available for FTH
FTH Financials
-
FTH total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Net income: -$21.09M (1Y), -$16.01M (Q2)
Net Income increased 30.08% since last year and increased 90.6% since last quarter.
-
Earnings per share: -$16.72 (1Y), -$2.84 (Q2)
EPS increased 30.35% since last year and increased 97.84% since last quarter.
Key terms
FTH Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
FTH Competitors
-
How competitors are chosen
FTH's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $851.96M
A market capitalization between $300 million and $2 billion places FTH in the small capitalization category.
Key terms
Latest investing news
-
Bond market takes a breather after surprise move by Treasury Department -
Global bond markets are getting hammered. Here’s why that could make your life more expensive -
‘Brazen act of self-dealing.’ Lawmakers, watchdogs alarmed after Trump regulators let Trump firm start a bank -
The S&P 500 is back at a record high and the Dow just hit 54,000
